Hehehe! Even EDGAR Filing beat BENZINGA with news release! Hehehe
$Immutep(IMMP.US$ Immutep Receives Regulatory Clearance For Phase I Study Of First-In-Class LAG-3 Agonist Antibody Designed To Treat Autoimmune Diseases
Benzinga· 5 mins ago
Benzinga· 5 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Ejirenaith : I'm still watching, no volume at the moment ~
会飞的牛牛 : Good news
Trytosaveabit OP 会飞的牛牛 : It is!